prices

Timophey Nizhegorodtsev: modernizing the drug pricing methods creates conditions to reduce prices for the most expensive drugs
FAS insists on including price objectification measures in the pricing techniques and creating conditions that facilitate entry to the market of non-expensive drugs
more
Rachik Petrosyan: functionalities of the Informational Analytical System allow to expose overrated prices in drug procurement
IAS functionalities already enables to estimate average weighted prices for drug procurement per unit of active substance for a particular International Non-Proprietary Name, thanks to which it is possible to expose overrates prices in the course of drug procurement
more
Court supported FAS in a dispute with UAPP
Moscow Arbitration Court supported FAS decision not to open a case upon a petition for the Union of Alcohol Products Producers (UAPP)
more
Igor Artemiev outlined the prospects of tariff regulation for the next few years
Igor Artemiev focused his report on 17 October 2017 at the workshop on “Tariff regulation in 2017 and regulators’ objectives for 2018 – 2025” in Crimea on the results and prospects of tariff regulation
more
Anatoly Golomolzin: “URALS crude will be quoted right on other crudes”
On 5 October 2017 Deputy Head of FAS Anatoly Golomolzin took part in “Russian Energy Week 2017”
more